The Effect of Early Sedation With Dexmedetomidine on Body Temperature in Critically Ill Patients*
- 23 February 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 49 (7), 1118-1128
- https://doi.org/10.1097/ccm.0000000000004935
Abstract
Objectives: Previous case series reported an association between dexmedetomidine use and hyperthermia. Temperature data have not been systematically reported in previous randomized controlled trials evaluating dexmedetomidine. A causal link between dexmedetomidine administration and elevated temperature has not been demonstrated. Design: Post hoc analysis. Setting: Four ICUs in Australia and New Zealand. Patients: About 703 mechanically ventilated ICU patients. Interventions: Early sedation with dexmedetomidine versus usual care. MEASUREMENTS AND MAIN RESULTS: The primary outcome was mean daily body temperature. Secondary outcomes included the proportions of patients with body temperatures greater than or equal to 38.3°C and greater than or equal to 39°C, respectively. Outcomes were recorded for 5 days postrandomization in the ICU. The mean daily temperature was not different between the dexmedetomidine (n = 351) and usual care (n = 352) groups (36.84°C ± SD vs 36.78°C ± SD; p = 0.16). Over the first 5 ICU days, more dexmedetomidine group (vs usual care) patients had a temperature greater than or equal to 38.3°C (43.3% vs 32.7%, p = 0.004; absolute difference 10.6 percentage points) and greater than or equal to 39.0°C (19.4% vs 12.5%, p = 0.013; absolute difference 6.9 percentage points). Results were similar after adjusting for diagnosis, admitting temperature, age, weight, study site, sepsis occurrence, and the time from dexmedetomidine initiation to first hyperthermia recorded. There was a significant dose response relationship with temperature increasing by 0.30°C ±0.08 for every additional 1 μg/kg/hr of dexmedetomidine received p < 0.0002. Conclusions: Our study suggests potentially important elevations in body temperature are associated with early dexmedetomidine sedation, in adults who are mechanically ventilated in the ICU.This publication has 26 references indexed in Scilit:
- Intensive care sedation: the past, present and the futureCritical Care, 2013
- Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective studyJournal of Anaesthesiology Clinical Pharmacology, 2012
- Adverse drug reactions resulting in hyperthermia in the intensive care unitCritical Care Medicine, 2010
- Thermoregulatory defense mechanismsCritical Care Medicine, 2009
- Postoperative Intensive Care Unit Drug Fever Caused by DexmedetomidineAnesthesia & Analgesia, 2009
- Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of AmericaCritical Care Medicine, 2008
- Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agentPediatric Anesthesia, 2006
- α2-Adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the α2A-adrenoceptor subtypeNeuropharmacology, 2003
- Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold in HumansStroke, 2003
- Clonidine Comparably Decreases the Thermoregulatory Thresholds for Vasoconstriction and Shivering in HumansAnesthesiology, 1993